Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2001-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.60.12.1117PMID 11709453PMCID PMC1753441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A disease severity scale for systemic sclerosis: development and testing.

  1999cited by this paper
• Mortality and causes of death in a Swedish series of systemic sclerosis patients

  1998cited by this paper
• Scleroderma--demographics and survival.

  1997cited by this paper
• Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis

  1997cited by this paper
• Predictors of survival in 171 patients with systemic sclerosis (scleroderma)

  1997cited by this paper
• Left ventricular myocardial perfusion and function in systemic sclerosis before and after diltiazem treatment.

  1996cited by this paper
• Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population.

  1996cited by this paper
• Severe restrictive lung disease in systemic sclerosis.

  1994cited by this paper
• Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide.

  1994cited by this paper
• Systemic sclerosis in Iceland. A nationwide epidemiological study.

  1994cited by this paper
• Predictors of survival in systemic sclerosis (scleroderma).

  1991cited by this paper
• Epidemiology and natural history of systemic sclerosis.

  1990cited by this paper
• Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma.

  1989cited by this paper
• Cineradiography identifies esophageal candidiasis in progressive systemic sclerosis.

  1989cited by this paper
• Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

  1988cited by this paper
• Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis.

  1986cited by this paper
• Ultrasound Examination of Skin Thickness in Patients with Progressive Systemic Sclerosis (Scleroderma)

  1986cited by this paper
• Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma.

  1984cited by this paper
• Use of the triolein breath test for the demonstration of fat malabsorption in coeliac disease.

  1984cited by this paper
• Factors predicting development of renal involvement in progressive systemic sclerosis.

  1984cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients.

  1971cited by this paper
• Survival in scleroderma.

  1971cited by this paper
• Epidemiology of systemic sclerosis (scleroderma).

  1971cited by this paper
• A method for determination of pulmonary elastic recoil and resistance at a regulated flow rate.

  1969cited by this paper
• Prognostic Significance of Raynaud's Phenomenon and Other Clinical Characteristics of Systemic Scleroderma: A Study of 271 Cases

  1960cited by this paper

• Gastrointestinal disorders in systemic sclerosis: cluster analysis and prognosis from a French prospective cohort.

  2024cites this paper
• Assessment of Neutrophil-Lymphocyte Ratio and Systemic Immune-Inflammation Index in Systemic Scleroderma Patients with Focus on Cardiopulmonary Manifestations

  2024cites this paper
• Prevalence of systemic sclerosis and atherosclerosis: A systemic review and meta-analysis

  2022cites this paper
• Systemic Sclerosis

  2022cites this paper
• A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis

  2022cites this paper
• Associations between the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis (CRISS), survival and other disease measures.

  2022cites this paper
• Ultrasound evaluation of bowel vasculopathy in systemic sclerosis.

  2022cites this paper
• The Correlation between Helicobacter Pylori Infection and Disease Severity in Patients with Systemic Sclerosis

  2021cites this paper
• Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis

  2021cites this paper
• Gender differences in organ involvement and survival in systemic sclerosis – experience of a EUSTAR center

  2021cites this paper
• Gender differences in clinical features and outcomes of a Portuguese systemic sclerosis cohort

  2021cites this paper
• Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS)

  2020cites this paper
• Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity.

  2019cites this paper
• Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis.

  2019cites this paper
• Survival, risk assessment and causes of death in a series of 439 patients with systemic sclerosis

  2018influential citation
• Quantifying organ damage in systemic sclerosis: rationale, methodology and item generation

  2018cites this paper
• The Journal of Tehran University Heart Center.

  2018cites this paper
• Quantifying the burden of systemic sclerosis in Australia: From data linkage to patient reported outcomes

  2018influential citation
• Measurement of Serum Klotho in Systemic Sclerosis

  2017cites this paper
• Measures of disease status in systemic sclerosis: A systematic review.

  2017influential citation
• The role of klotho in systemic sclerosis.

  2017cites this paper
• Distinct mortality profile in systemic sclerosis: a death certificate study in Rio de Janeiro, Brazil (2006–2015) using a multiple causes of death analysis

  2017cites this paper
• Early Accrual of Organ Damage in Systemic Sclerosis: Rationale for Development of a Disease Damage Index

  2017cites this paper
• Survival, Mortality, Causes of Death and Risk Factors of Poor Outcome

  2017cites this paper
• Assessment of nailfold capillaries with a handheld dermatoscope may discriminate the extent of organ involvement in patients with systemic sclerosis

  2016cites this paper
• Primary myocardial disease in scleroderma-a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group.

  2016cites this paper
• Acro-osteolysis as an Indicator of Severity in Systemic Sclerosis ☆

  2016cites this paper
• Anti-Collagen Type V Antibody in Systemic Sclerosis: A Possible Useful Tool to Asses Disease Activity

  2016cites this paper
• Acro-osteolysis as an indicator of severity in systemic sclerosis.

  2016cites this paper
• Musculoskeletal Manifestations of Systemic Sclerosis.

  2015cites this paper
• A three-year follow-up study of the development of joint contractures in 131 patients with systemic sclerosis.

  2014cites this paper
• Seminars in Arthritis and Rheumatism

  2014cites this paper
• Cambios en el patrón de mortalidad de la cohorte del registro español de esclerodermia

  2014cites this paper
• Ultrasound assessment of ex vivo lung tissue properties using a fluid-filled negative pressure bath.

  2014cites this paper
• The Effect of Male Sex on Survival in Systemic Sclerosis

  2014cites this paper
• Mortality and survival in systemic sclerosis: systematic review and meta-analysis.

  2014influential citation
• A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study

  2014cites this paper
• Mortality in systemic sclerosis—a single centre study from the UK

  2013cites this paper
• Atypical Ground Glass Opacification in Systemic Sclerosis Related Interstitial Lung Disease: A Case Report. -

  2013cites this paper
• Survival and Causes of Death in an Unselected and Complete Cohort of Norwegian Patients with Systemic Sclerosis

  2013cites this paper
• Scleroderma renal crisis precipitated by steroid treatment in systemic lupus erythematosus and scleroderma overlap syndrome.

  2012cites this paper
• Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies.

  2012cites this paper
• A preliminary disease severity score for juvenile systemic sclerosis.

  2012cites this paper
• Measuring Disease Activity and Outcomes in Clinical trials

  2012cites this paper
• Assessments of pulmonary involvement in patients with systemic sclerosis.

  2011cites this paper
• Hematopoietic stem cell transplantation for systemic sclerosis: history and current status

  2011cites this paper
• Assessing disease activity and outcome in scleroderma

  2011cites this paper
• Preliminary Study of Cardiovascular Manifestations and Cardiac Severity Scale in 58 Patients with Systemic Sclerosis in Iran Using the Medsger Scale

  2010cites this paper
• СИСТЕМНАЯ СКЛЕРОДЕРМИЯ С ИНТЕРСТИЦИАЛЬНЫМПОРАЖЕНИЕМ ЛЕГКИХ: СРАВНИТЕЛЬНАЯ КЛИНИЧЕСКАЯХАРАКТЕРИСТИКА С БОЛЬНЫМИ БЕЗ ПОРАЖЕНИЯ ЛЕГКИХ

  2010cites this paper
• What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort? Results from the Canadian Scleroderma Research Group (CSRG)

  2010cites this paper
• Prevalence of scleroderma in Spain: an approach for estimating rare disease prevalence using a disease model

  2008cites this paper
• Biomarkers in systemic sclerosis.

  2008cites this paper
• High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease.

  2008cites this paper
• Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease.

  2008cites this paper
• Six Minute Walk Test As An Assessment Tool In Systemic Sclerosis

  2008cites this paper
• Pulmonary arterial hypertension in Thai patients with systemic sclerosis.

  2008cites this paper
• Autologous hematopoietic stem cell transplantation for systemic sclerosis

  2008cites this paper
• High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms.

  2008cites this paper
• Mortality in systemic sclerosis.

  2008cites this paper
• severe systemic sclerosis haematopoietic stem cell transplantation for Long-term follow-up results after autologous

  2008cites this paper
• Update on indices of disease activity in systemic sclerosis.

  2007cites this paper
• The relationship of dyspnoea to function and quality of life in systemic sclerosis

  2007cites this paper
• Survival and causes of death in 366 Hungarian patients with systemic sclerosis

  2007cites this paper
• Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis

  2007cites this paper
• Advanced systemic sclerosis complicated by pulmonary hypertension and complete atrioventricular block: a case report.

  2007cites this paper
• Using a self-reported functional score to assess disease progression in systemic sclerosis.

  2007cites this paper
• Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients.

  2007cites this paper
• Clinical Assessment in Systemic Sclerosis

  2007cites this paper
• [Systemic sclerosis and the gastrointestinal tract. Diagnostic and therapeutic approach].

  2006cites this paper
• cirrhosis associated with systemic sclerosis Clinical features and prognosis of primary biliary

  2006cites this paper
• Esclerosis sistémica y tracto gastrointestinal. Abordaje diagnóstico y terapéutico

  2006cites this paper
• Avaliação do comprometimento pulmonar em pacientes com esclerodermia por meio do teste da caminhada de seis minutos

  2006cites this paper
• Esclerosis sistémica y tracto gastrointestinal. Abordaje diagnóstico y terapéutico

  2006cites this paper
• Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis

  2005cites this paper
• Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature.

  2005cites this paper
• Kidney crisis in systemic sclerosis.

  2005cites this paper
• Prevalência de achados cutâneos em portadores de esclerose sistêmica: experiência de um hospital universitário

  2005cites this paper
• P305 - Les sclérodermies : particularités épidémio-cliniques à travers une série hospitalière de 156 cas

  2005cites this paper
• Mortality in systemic sclerosis: an international meta-analysis of individual patient data.

  2005cites this paper
• Prevalence of cutaneous findings in systemic sclerosis patients-Experience of a teaching hospital *

  2005cites this paper
• Juvenile Systemic Sclerosis: A Follow‐up Study of Eight Patients

  2005cites this paper
• Resting and exercise physiology in interstitial lung diseases.

  2004cites this paper
• Scleroderma renal crisis: the sword of damocles.

  2004cites this paper
• Manual of signs, symptoms, methods and procedures for the assessment of the patient with SSc.

  2003cites this paper
• Scleroderma epidemiology.

  2003cites this paper
• Assessment of disease severity and prognosis.

  2003cites this paper
• Predictors and outcomes of scleroderma renal crisis: data from the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.

  2002cites this paper
• Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.

  2002cites this paper
• Scleroderma in children

  2002cites this paper
• Disease severity as a predictor of outcome in scleroderma.

  2002cites this paper
• Scleroderma Lung Disease

  1997cites this paper